Evaluating Synergy
Statistical Design and Analysis of Drug Combination Studies
$120.89
- Hardcover
256 pages
- Release Date
2 February 2027
Summary
Design and analyze drug combination studies with statistical precision
Identifying synergistic drug combinations requires rigorous statistical methodology to distinguish true interactions from simple additivity. Evaluating Synergy: Statistical Design and Analysis of Drug Combination Studies presents modern methods for optimally designing and analyzing combination studies in cancer, antiviral, and other therapeutic areas. Written by biostatisticians and a phys…
Book Details
| ISBN-13: | 9780470669693 |
|---|---|
| ISBN-10: | 0470669691 |
| Author: | Ming Tan, Hongbin Fang, Douglas Ross |
| Publisher: | John Wiley & Sons Inc |
| Imprint: | John Wiley & Sons Inc |
| Format: | Hardcover |
| Number of Pages: | 256 |
| Release Date: | 2 February 2027 |
| Dimensions: | 168mm x 244mm |
| Series: | Statistics in Practice |

Ming Tan
Ming T. Tan is a professor in the Department of Biostatistics, Bioinformatics, and Biomathematics at Georgetown University School of Medicine and Georgetown Lombardi Comprehensive Cancer Centre, and a Fellow of the American Statistical Association. He has published more than 250 articles, numerous book chapters, and a book on statistical methods in biomedical research. He has previously held positions at the Cleveland Clinic, St. Jude Children’s Research Hospital, and the University of Maryland School of Medicine.
Hong-Bin Fang is an Associate Professor in the Department of Biostatistics, Bioinformatics, and Biomathematics at Georgetown University School of Medicine and the Lombardi Comprehensive Cancer Center. He has more than twenty years of experience in statistical design and analysis of cancer research studies, focusing on preclinical models, drug combinations, and high-dimensional genomic data.
Douglas D. Ross, MD, PhD, is Professor of Medicine, Pathology, Pharmacology, and Experimental Therapeutics and former Director of the Program in Experimental Therapeutics at the University of Maryland School of Medicine. He is a board-certified medical oncologist recognized worldwide for his work in mechanisms of drug action and drug resistance.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.



